Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 22, 2022
Patent Application Number
16746769
Date Filed
January 17, 2020
Patent Citations
...
Patent Primary Examiner
Patent abstract
1,8-naphthyridinone compounds as modulators of an adenosine receptor are provided. The compounds may find use as therapeutic agents for the treatment of diseases mediated through a G-protein-coupled receptor signaling pathway and may find particular use in oncology.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.